IKS Health IPO: Inventurus Knowledge Solutions Ltd., commonly known as IKS Health, recently concluded its IPO with a high level of investor interest. The IPO was exclusively an Offer For Sale (OFS) of 1.88 crore equity shares totaling ₹2,498 crore and it took place between December 12 2024, and December 16 2024.
Subscription Data:
Due to the overwhelming demand, the issue was 52.68 times oversubscribed. The following are the subscription figures:
Qualified Institutional Buyers (QIBs): This group had the most demand, with an 80.64-fold increase in subscriptions.
NIIs (non-institutional investors): 23.25 subscriptions.
Retail Individual Investors (RIIs): 14.55 subscriptions were made by the retail segment.
Workers: 5.2 subscriptions were recorded by the employees’ category.
Grey Market Premium (GMP) and Price Range:
The IPO price range is ₹1,265 to ₹1,329 per share. As of December 17, 2024, the GMP for the same is ₹421 per share. Therefore, ₹1,750 per share would be the anticipated listing price. Listing gains are around 31.68% as a result.
Dates of allocation and listing: Inventurus Knowledge Solutions Ltd.
It is anticipated that the share allocation will be finished on December 17 2024. Investors can check the registrar’s website in the BSE or NSE to see their allotment status. By December 18 2024, the allotted shares will be credited to the successful allottees’ demat accounts. On the same day, refunds to non-allottees will be handled. On December 19, 2024, the shares are probably going to be launched on the BSE and NSE. On December 17 2024, the share distribution will be finalized. Investors can visit the registrar’s website, While reimbursements for non-allottees are handled the same day, shares will be credited to the demat accounts of the successful allottees by December 18, 2024. On December 19, 2024, the shares will be listed on the NSE and BSE.
Overview of the Company
One of the leading providers of healthcare support services-IKS Health, combines human experience with technology to give superior healthcare services. It serves a wide spectrum of clients, including academic medical centers, multispecialty physician groups and health systems. Under the leadership of the Jhunjhunwala family, IKS Health IPO has grown significantly by utilizing technological innovations like artificial intelligence to provide effective solutions in the US healthcare sector.
Conclusion
Due to the high level of investor confidence in IKS Health business strategy and growth prospects, the company’s initial public offering (IPO) has garnered a lot of attention. IKS Health, which combines technology with service delivery, stands to gain a great deal as healthcare continues to change. As a result, it is recommended that investors keep up with any updates on these kinds of investment opportunities and other information that may help them make decisions.
Start small, stay consistent, and watch your money grow with IKS Health by creating a demat account in Angel One.
(Disclaimer: Demat Dive is not giving any buying advice on any stock. Consult a SEBI registered advisor before investing anywhere.)
Authored by – Deepa Trivedi
IKS Health IPO
Shares
